DRL acquires injectable portfolio from US-based Eton Pharma for $50 million
Dr. Reddy’s on Friday announced that it has acquired a portfolio of branded and generic injectable products from
Deer Park, Illinois, based Eton Pharmaceuticals. Under the terms of the…
Read More...
Read More...